Gene therapy of chronic liver injury with RNAi vector targeting TGF-beta receptor
RNAi载体靶向TGF-β受体基因治疗慢性肝损伤
基本信息
- 批准号:16591364
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transforming growth factor beta (TGF-B) receptor II (TGF-BRII), which is essential for TGF-B signaling and is involved in the causation or participates in the pathway of various human disorders, is consequently considered a key target for therapeutics and analysis of the pathophysiology associated with disruption of the TGF-B system. In the liver, TGF-B plays an essential role in hepatocyte apoptosis, growth inhibition, and progression of fibrogenesis. There is a critical need to introduce technology involving the TGF-B system, such as RNA interference (RNAi), which has high potential for in vivo therapeutics and analytical activities. Here, we investigated the effect of short hairpin RNA targeting TGF-BRII, using hepatocyte injury in human and mouse cell lines and liver injury mouse models. We demonstrated that short hairpin RNA targeting TGF-BRII can be used to silence TGF-BRII genes in mouse and human cell lines, and physiologic and morphologic changes in hepatocytes suffering from acute injury are spared by RNAi-mediated gene silencing of the target gene and by suppressing downstream signal transduction. Furthermore, short hairpin RNA targeting TGF-BRII protected mice from life-threatening acute liver failure.
转化生长因子β(TGF-B)受体II(TGF-BRII)是TGF-B信号传导所必需的,并且参与各种人类疾病的病因或参与各种人类疾病的途径,因此被认为是治疗和分析与TGF-B系统破坏相关的病理生理学的关键靶标。在肝脏中,TGF-β在肝细胞凋亡、生长抑制和纤维化进展中起重要作用。迫切需要引入涉及TGF-B系统的技术,例如RNA干扰(RNAi),其具有很高的体内治疗和分析活性潜力。在这里,我们研究了靶向TGF-BRII的短发夹RNA的作用,使用人和小鼠细胞系中的肝细胞损伤和肝损伤小鼠模型。我们证明了靶向TGF-BRII的短发夹RNA可用于沉默小鼠和人细胞系中的TGF-BRII基因,并且通过RNAi介导的靶基因沉默和抑制下游信号转导,免于急性损伤的肝细胞的生理和形态变化。此外,靶向TGF-BRII的短发夹RNA保护小鼠免于危及生命的急性肝衰竭。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sequences of RNA functioning as RNA interference targeting human and mouse transforming growth factor beta1 receptor 2
作为针对人和小鼠转化生长因子β1受体2的RNA干扰的RNA序列
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sequences of RNA functioning as RNA interference targeting human and mouse transforming growth factor betal receptor 2
作为针对人和小鼠转化生长因子β受体2的RNA干扰的RNA序列
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Short hairpin RNA modulates transforming growth factor beta signaling in life-threatening liverfailure in mice.
短发夹 RNA 在危及生命的小鼠肝衰竭中调节转化生长因子 β 信号传导。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Mizuguchi Y;Yokomuro S;Mishima T;Arima Y;Shimizu T;Kawahigashi Y;Kanda T;Yoshida H;Takizawa T;Tajiri T.
- 通讯作者:Tajiri T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAJIRI Takashi其他文献
TAJIRI Takashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAJIRI Takashi', 18)}}的其他基金
Sequencing based quantitative and qualitative analyses of the microRNA transcriptome in hepatitis B related hepatocellular carcinoma.
基于测序的乙型肝炎相关肝细胞癌 microRNA 转录组的定量和定性分析。
- 批准号:
18390372 - 财政年份:2006
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Changes in Distribution of Splenic Venous Flow in the Patients with Cirrhotic Liver
肝硬化患者脾静脉流量分布的变化
- 批准号:
13671350 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
9254540 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
9050669 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
8882981 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
6176259 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
6802280 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
7232435 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
6614387 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
2414851 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
6517279 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别:
LIVER REPOPULATION FOR LIVER INJURY AND GENE THERAPY
肝损伤的肝脏再生和基因治疗
- 批准号:
2623453 - 财政年份:1994
- 资助金额:
$ 2.18万 - 项目类别: